Saraswati Saree Depot Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

SSDL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.9%Reaction day

₹95.00

prior close

₹95.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+5.8% vs market

Garments & Apparels peers, median of 36sector+0.0%+5.9% vs sector

On the reaction day the stock moved 5.8 pts more than Nifty Microcap 250 and 5.9 pts more than its Garments & Apparels peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+8.9

10m

+5.3

15m

+5.8

30m

+5.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.9+0.1+5.8+0.0+5.9

Next day

+3.2-0.2+3.3-0.9+4.0

+4.8+0.3+4.5+0.1+4.7

+6.3+0.9+5.4+0.7+5.5

+4.8+0.8+4.0+0.1+4.6

+9.6+2.2+7.4+0.9+8.7

+11.6+3.4+8.2+2.4+9.2

15d

-0.1-0.8+0.7-1.4+1.3

+2.8+2.9-0.2-0.2+3.0

-3.4+0.8-4.3-3.3-0.1

-5.3+0.0-5.3-9.3+4.0

UpDownMarket · Nifty Microcap 250Sector · Garments & Apparels peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Saraswati Saree Depot Limited has submitted its audited financial results for the financial year ended March 31, 2025 to the stock exchange. The headline announcement confirms the filing has been made but does not disclose the actual revenue, profit, or other financial figures. Investors will need to review the detailed results document to assess the company's performance for FY25. The filing marks the formal closure of the company's annual reporting cycle for the fiscal year.

Likely market impact

Neutral on its face — this is a routine regulatory filing confirming submission of results. The actual impact on shareholders will depend on the numbers in the detailed results, which have not been disclosed in this headline.